Thymalin

Compound Overview

Thymalin is a bioregulatory peptide complex originally obtained from calf thymus tissue. Its primary active component is the dipeptide Glu-Trp. In controlled research settings, investigators study this compound in relation to immunomodulatory effects on T-cell maturation, thymic function restoration, and immune homeostasis signaling.

Research Background & Published Literature

Prof. Vladimir Khavinson developed Thymalin within the bioregulatory peptide research program at the Saint Petersburg Institute. Related research has appeared in Bulletin of Experimental Biology and Medicine and Advances in Gerontology.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Khavinson VKh et al. (2003) — Neuro Endocrinol Lett
• Khavinson et al. (2020) — Bull Exp Biol Med
• Khavinson VKh (2002) — Neuro Endocrinol Lett

Storage, Handling & Stability Guidelines

For long-term stability, store lyophilized Thymalin material at -20°C. After reconstitution with sterile diluent, keep the preparation refrigerated at 2–8°C and reduce freeze-thaw exposure by aliquoting working volumes according to your laboratory's standard operating procedures.

• Keep ambient-temperature handling time as short as practical to support compound integrity.
• Reseal vials promptly after each withdrawal to limit moisture exposure.
• Use appropriate personal protective equipment and follow institutional chemical safety protocols at all times.
• For traceability, label all aliquots with compound name, concentration, reconstitution date, and operator initials.

Lab Verification

Nexus maintains batch-level verification records for research compounds in the Lab Verified archive, including identity review, potency documentation, and analytical release details where current lot data is available.